Sign in
Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First Time 26-Week Interim Analysis Results from the Phase 2 LUNA Study
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2024
Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID
Rishi P. Singh, MD
Annual Meeting Talks
2019
Results of Perimetry at Age of 10 Years in Severe ROP Eyes Receiving Laser or Anti-VEGF Treatment as Primary Monotherapy
Alay S. Banker, MD
2020
Category: Pediatric Retina